Balcom Alexandra's most recent trade in Nuvalent Inc - Ordinary Shares - Class A was a trade of 37,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 6, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 37,500 | 37,500 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 18,750 | 65,750 | - | 0 | Class A Common Stock | |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 80.54 per share. | 06 Jan 2025 | 2,173 | 61,734 | - | 80.5 | 175,013 | Class A Common Stock |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 78.28 per share. | 06 Jan 2025 | 1,152 | 64,598 | - | 78.3 | 90,179 | Class A Common Stock |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 79.33 per share. | 06 Jan 2025 | 691 | 63,907 | - | 79.3 | 54,817 | Class A Common Stock |
| Nuvalent Inc - Ordinary Sh... | Balcom Alexandra | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.89 per share. | 17 Dec 2024 | 8,972 | 47,000 | - | 6.9 | 61,817 | Class A Common Stock |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2024 | 8,972 | 87,226 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 17 Dec 2024 | 4,728 | 38,028 | - | 1.1 | 5,106 | Class A Common Stock |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2024 | 4,728 | 196,156 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc - Ordinary Sh... | Balcom Alexandra | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.85 per share. | 29 Nov 2024 | 10,000 | 43,300 | - | 27.9 | 278,500 | Class A Common Stock |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Nov 2024 | 10,000 | 84,200 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 95.69 per share. | 29 Nov 2024 | 8,142 | 35,158 | - | 95.7 | 779,108 | Class A Common Stock |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 96.25 per share. | 29 Nov 2024 | 1,858 | 33,300 | - | 96.3 | 178,833 | Class A Common Stock |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.85 per share. | 31 Oct 2024 | 10,000 | 43,300 | - | 27.9 | 278,500 | Class A Common Stock |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2024 | 10,000 | 94,200 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 89.17 per share. | 31 Oct 2024 | 6,320 | 35,000 | - | 89.2 | 563,554 | Class A Common Stock |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 88.25 per share. | 31 Oct 2024 | 1,980 | 41,320 | - | 88.3 | 174,735 | Class A Common Stock |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 90.31 per share. | 31 Oct 2024 | 1,600 | 33,400 | - | 90.3 | 144,496 | Class A Common Stock |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 90.94 per share. | 31 Oct 2024 | 100 | 33,300 | - | 90.9 | 9,094 | Class A Common Stock |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2024 | 10,000 | 104,200 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.85 per share. | 30 Sep 2024 | 10,000 | 43,300 | - | 27.9 | 278,500 | Class A Common Stock |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 101.13 per share. | 30 Sep 2024 | 5,032 | 36,263 | - | 101.1 | 508,886 | Class A Common Stock |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 101.89 per share. | 30 Sep 2024 | 2,963 | 33,300 | - | 101.9 | 301,900 | Class A Common Stock |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 100.09 per share. | 30 Sep 2024 | 1,305 | 41,295 | - | 100.1 | 130,617 | Class A Common Stock |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 98.88 per share. | 30 Sep 2024 | 700 | 42,600 | - | 98.9 | 69,216 | Class A Common Stock |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Aug 2024 | 10,000 | 114,200 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.85 per share. | 30 Aug 2024 | 10,000 | 43,300 | - | 27.9 | 278,500 | Class A Common Stock |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 83.87 per share. | 30 Aug 2024 | 5,231 | 38,069 | - | 83.9 | 438,724 | Class A Common Stock |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 84.55 per share. | 30 Aug 2024 | 4,481 | 33,588 | - | 84.6 | 378,869 | Class A Common Stock |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 85.96 per share. | 30 Aug 2024 | 288 | 33,300 | - | 86.0 | 24,756 | Class A Common Stock |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2024 | 10,000 | 124,200 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.85 per share. | 31 Jul 2024 | 10,000 | 43,300 | - | 27.9 | 278,500 | Class A Common Stock |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 79.44 per share. | 31 Jul 2024 | 5,723 | 36,084 | - | 79.4 | 454,635 | Class A Common Stock |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 80.38 per share. | 31 Jul 2024 | 1,649 | 34,435 | - | 80.4 | 132,547 | Class A Common Stock |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 81.31 per share. | 31 Jul 2024 | 1,135 | 33,300 | - | 81.3 | 92,287 | Class A Common Stock |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 77.02 per share. | 31 Jul 2024 | 896 | 42,404 | - | 77.0 | 69,010 | Class A Common Stock |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 78.05 per share. | 31 Jul 2024 | 597 | 41,807 | - | 78.1 | 46,596 | Class A Common Stock |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.85 per share. | 28 Jun 2024 | 10,000 | 43,300 | - | 27.9 | 278,500 | Class A Common Stock |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jun 2024 | 10,000 | 134,200 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 75.15 per share. | 28 Jun 2024 | 7,565 | 35,735 | - | 75.2 | 568,510 | Class A Common Stock |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 76.19 per share. | 28 Jun 2024 | 1,863 | 33,872 | - | 76.2 | 141,942 | Class A Common Stock |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 76.73 per share. | 28 Jun 2024 | 572 | 33,300 | - | 76.7 | 43,890 | Class A Common Stock |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 47,500 | 47,500 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 33,300 | 33,300 | - | 0 | Class A Common Stock | |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Dec 2023 | 30,000 | 200,884 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc - Ordinary Sh... | Balcom Alexandra | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 75.82 per share. | 18 Dec 2023 | 30,000 | 0 | - | 75.8 | 2,274,600 | Class A Common Stock |
| Nuvalent Inc - Ordinary Sh... | Balcom Alexandra | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 18 Dec 2023 | 30,000 | 30,000 | - | 1.1 | 32,400 | Class A Common Stock |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 31 Jul 2023 | 25,000 | 25,000 | - | 1.1 | 27,000 | Class A Common Stock |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2023 | 25,000 | 230,884 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 48.61 per share. | 31 Jul 2023 | 14,152 | 10,848 | - | 48.6 | 687,929 | Class A Common Stock |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 49.49 per share. | 31 Jul 2023 | 10,848 | 0 | - | 49.5 | 536,868 | Class A Common Stock |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 144,200 | 144,200 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc - Ordinary Sh... | Alexandra Balcom | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2022 | 107,000 | 107,000 | - | - | Stock Option (Right to Buy) |